Chavy Arora
Biographic Data
| ID | 7990010 |
|---|---|
| NAME | Chavy Arora |
| GIVEN NAMES | Chavy |
| FAMILY NAME | Arora |
| SIGNATURE | ARORA C |
| AFFILIATIONS | Wellcome Centre for Ethics and Humanities |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
When is the use of suboptimal treatment in functionally untreatable multi-drug resistant tuberculosis morally permissible
Multidrug-resistant tuberculosis (MDR-TB) is well recognised as a serious threat to controlling and ending the TB epidemic. Treatment is time-intensive and costly. Current treatment guidelines recommend the use of at least four effective drugs plus pyrazinamide for a period of 18-24 months. There are, however, situations in which this is not feasible. This may be due to severe patterns of drug-resistance, poor tolerance to the medications, or sup…
No prominent works on this page.
When is the use of suboptimal treatment in functionally untreatable multi-drug resistant tuberculosis morally permissible
Multidrug-resistant tuberculosis (MDR-TB) is well recognised as a serious threat to controlling and ending the TB epidemic. Treatment is time-intensive and costly. Current treatment guidelines recommend the use of at least four effective drugs plus pyrazinamide for a period of 18-24 months. There are, however, situations in which this is not feasible. This may be due to severe patterns of drug-resistance, poor tolerance to the medications, or sup…
Dilemma (1 work) · Drug (1 work) · Drug resistance (1 work) · Ethics in medical practice (1 work) · Extensively drug-resistant tuberculosis (1 work) · Intensive care medicine (1 work) · Interim (1 work) · Limiting (1 work) · Medicine (1 work) · Mycobacterium tuberculosis (1 work)